ArticleTargeted oncology2025
Cardiotoxicity Profiles of Osimertinib Compared with Other EGFR Tyrosine Kinase Inhibitors: A Real-World Comparative Incidence Analysis.
Zaid Muhanna et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this paperpooled itcites it